{"id":"https://openalex.org/W3213856433","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.385","title":"385 Identification and enrichment of neoantigen-reactive T cells to optimize adoptive cell transfer with tumor-infiltrating lymphocytes (TIL)","display_name":"385 Identification and enrichment of neoantigen-reactive T cells to optimize adoptive cell transfer with tumor-infiltrating lymphocytes (TIL)","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3213856433","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.385","mag":"3213856433"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.385","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.385","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.385","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A419.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A419.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002314862","display_name":"MacLean S. Hall","orcid":"https://orcid.org/0000-0002-5626-1619","observed_orcids":["https://orcid.org/0000-0002-5626-1619"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MacLean Hall","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020645743","display_name":"Holly Branthoover","orcid":"https://orcid.org/0000-0001-7808-1662","observed_orcids":["https://orcid.org/0000-0001-7808-1662"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Holly Branthoover","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017077649","display_name":"Matthew S. Beatty","orcid":"https://orcid.org/0000-0003-3198-9264","observed_orcids":["https://orcid.org/0000-0003-3198-9264"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Beatty","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032796888","display_name":"Kwame Twumasi\u2010Boateng","orcid":"https://orcid.org/0009-0005-1209-036X","observed_orcids":["https://orcid.org/0009-0005-1209-036X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kwame Twumasi-Boateng","raw_affiliation_strings":["Turnstone Biologics, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Turnstone Biologics, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029982031","display_name":"Jim Bender","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jim Bender","raw_affiliation_strings":["Turnstone Biologics, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Turnstone Biologics, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004345393","display_name":"Jake Ceccarelli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jake Ceccarelli","raw_affiliation_strings":["Turnstone Biologics, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Turnstone Biologics, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084474323","display_name":"Timothy J Langer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TJ Langer","raw_affiliation_strings":["Turnstone Biologics, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Turnstone Biologics, New York, NY, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049848426","display_name":"Jamie K. Teer","orcid":"https://orcid.org/0000-0003-4513-0282","observed_orcids":["https://orcid.org/0000-0003-4513-0282"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie Teer","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073250291","display_name":"Amod Sarnaik","orcid":"https://orcid.org/0000-0002-2337-5898","observed_orcids":["https://orcid.org/0000-0002-2337-5898"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amod Sarnaik","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006278901","display_name":"Shari Pilon\u2010Thomas","orcid":"https://orcid.org/0000-0001-7785-3034","observed_orcids":["https://orcid.org/0000-0001-7785-3034"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shari Pilon-Thomas","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A419","last_page":"A419"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5938000082969666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5938000082969666,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.28220000863075256,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.09989999979734421,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.7630000114440918},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9890000224113464},{"id":"https://openalex.org/keywords/adoptive-cell-transfer","display_name":"adoptive cell transfer","score":0.9789999723434448},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/t-cell-enrichment","display_name":"T cell enrichment","score":0.6759999990463257},{"id":"https://openalex.org/keywords/rapid-expansion-protocol","display_name":"rapid expansion protocol","score":0.890999972820282},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.6330000162124634},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.5849999785423279},{"id":"https://openalex.org/keywords/t-cell-degranulation","display_name":"T cell degranulation","score":0.578000009059906},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.33500000834465027}],"concepts":[{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.7194896936416626},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.6362972855567932},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5777808427810669},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5754321813583374},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.48623695969581604},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.46613308787345886},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4428558051586151},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4410861134529114},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4355069100856781},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32916152477264404},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.23673862218856812},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.22752031683921814},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21439781785011292},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15767782926559448},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.385","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.385","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.385","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A419.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.385","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.385","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.385","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A419.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3213856433.pdf","grobid_xml":"https://content.openalex.org/works/W3213856433.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387440965","https://openalex.org/W3211785685","https://openalex.org/W2402214060","https://openalex.org/W4388047749","https://openalex.org/W4415898809","https://openalex.org/W2913640925","https://openalex.org/W2522526918","https://openalex.org/W2074788814","https://openalex.org/W2797920124","https://openalex.org/W7019693500"],"abstract_inverted_index":{"Background":[0],"Adoptive":[1],"cell":[2],"transfer":[3],"(ACT)":[4],"using":[5],"tumor-infiltrating":[6],"lymphocytes":[7],"(TIL)":[8],"has":[9],"achieved":[10],"an":[11],"overall":[12],"response":[13,41],"rate":[14],"of":[15,31,87,112,269,275,295,310,330,336,390,397],"39%":[16],"in":[17,327,341],"metastatic":[18,115,128,254,358],"melanoma":[19,116,129,255,359],"patients":[20,32],"at":[21],"Moffitt":[22],"Cancer":[23],"Center.":[24],"In":[25],"these":[26,373],"trials,":[27],"a":[28,39,292,301],"substantial":[29,308],"fraction":[30],"were":[33,132,142,165,173,192,199,213,236,271,362],"non-responders":[34],"by":[35,76,99,216,242,409,417,425],"RECIST,":[36],"but":[37],"demonstrated":[38],"mixed":[40],"to":[42,64,91,94,154,167,179,188,221,260,324,352,394],"therapy.":[43],"These":[44,211,382],"results":[45],"suggest":[46],"that":[47,71],"the":[48,108,229,283,388],"infused":[49],"TIL":[50,81,106,125,130,212,235,270,290,299,322,339,356,392],"product":[51,111],"contained":[52],"tumor-reactive":[53],"T":[54],"cells":[55,204],"with":[56,67,97,208,279,282,307],"therapeutic":[57],"potential,":[58],"which":[59,368],"could":[60],"be":[61,74,180],"further":[62,385],"optimized":[63],"improve":[65],"ACT":[66,96,109],"TIL.":[68,210,354,381],"We":[69],"hypothesized":[70],"outcomes":[72],"might":[73],"improved":[75],"identifying":[77],"and":[78,102,124,139,146,152,161,186,206,224,226,247,313,319,348],"enriching":[79],"neoantigen-reactive":[80,366],"within":[82],"bulk":[83],"products.":[84],"The":[85],"purpose":[86],"this":[88,135],"study":[89],"is":[90],"define":[92],"approaches":[93],"optimize":[95],"TIL,":[98,367],"identifying,":[100],"enriching,":[101],"analyzing":[103],"neoantigen":[104,240,284],"reactive":[105],"from":[107,126,149,156,253,258,357],"infusion":[110],"previously":[113],"treated":[114],"patients.":[117],"Methods":[118],"Patient-derived":[119],"cryopreserved":[120],"tumor":[121,150],"tissue,":[122],"PBMC,":[123],"completed":[127],"trials":[131],"used":[133],"for":[134,176,239,273,365],"study.":[136],"Whole":[137],"exome":[138],"RNA":[140,147],"sequencing":[141,160],"performed":[143],"on":[144,182,218],"DNA":[145,155],"extracted":[148],"tissue":[151],"compared":[153,351,379],"autologous":[157,209],"PBMC.":[158],"Genetic":[159],"gene":[162],"expression":[163],"data":[164,383],"utilized":[166],"determine":[168],"protein-modifying":[169],"somatic":[170,251],"mutations.":[171],"Peptides":[172],"then":[174,214],"predicted":[175,374],"their":[177,219],"ability":[178,220],"presented":[181],"MHC":[183],"molecules,":[184],"prioritized,":[185],"up":[187],"192":[189],"custom":[190],"25-mers":[191],"synthesized":[193],"per":[194],"patient":[195,360],"sample.":[196],"Neoantigen":[197],"peptides":[198,375],"loaded":[200],"onto":[201],"patient-derived":[202],"dendritic":[203],"(DC)":[205],"co-cultured":[207],"sorted":[215,272],"FACS":[217],"upregulate":[222],"41BB":[223],"OX40":[225],"expanded":[227,323],"through":[228],"rapid":[230],"expansion":[231],"protocol":[232],"(REP).":[233],"Enriched":[234],"subsequently":[237],"screened":[238],"reactivity":[241,371],"41BB/OX40":[243,276],"upregulation,":[244],"cytokine":[245],"release,":[246],"degranulation.":[248],"Results":[249],"Protein-altering":[250],"mutations":[252,262],"tissues":[256],"ranged":[257],"49":[259],"1631":[261],"(median":[263],"=":[264],"389).":[265],"On":[266],"average,":[267],"16.2%":[268],"upregulation":[274,294],"upon":[277,376],"co-culture":[278],"DC":[280],"pulsed":[281],"peptide":[285],"pool":[286],"(range:":[287],"2.7\u201331.1%).":[288],"CD4+":[289],"displayed":[291],"3.75-fold":[293],"41BB/OX40,":[296],"while":[297],"CD8+":[298],"saw":[300],"1.88-fold":[302],"increase":[303],"(n=6).":[304,316],"This":[305],"coincided":[306],"production":[309],"IFN\u03b3,":[311,347],"TNF\u03b1,":[312],"granzyme":[314],"B":[315],"Neoantigen-reactive":[317],"(41BB+/OX40+)":[318],"non-reactive":[320,353,380],"(41BB-/OX40-)":[321],"similar":[325],"degrees":[326],"REP":[328],"(average":[329],"639-fold":[331],"vs.":[332],"611-fold;":[333],"n=6).":[334],"Restimulation":[335],"enriched":[337,364],"neoantigen-specific":[338],"resulted":[340],"superior":[342],"pro-inflammatory":[343],"functionality":[344],"(granzyme":[345],"B,":[346],"TNF\u03b1)":[349],"when":[350,378],"Conclusions":[355],"samples":[361],"successfully":[363],"maintained":[369],"increased":[370],"against":[372],"restimulation":[377],"support":[384],"investigation":[386],"into":[387],"use":[389],"neoantigen-enriched":[391],"products":[393],"enhance":[395],"efficacy":[396],"ACT.":[398],"Trial":[399],"Registration":[400],"NCT01005745,":[401],"NCT01659151,":[402],"NCT01701674":[403],"Ethics":[404],"Approval":[405],"NCT01005745":[406],"was":[407,415,423],"approved":[408,416,424],"USF":[410,426],"IRB":[411,419,427],"approval":[412,420,428],"number":[413,421,429],"Ame5_107905.NCT01659151":[414],"Advarra":[418],"14.03.0083.NCT01701674":[422],"Ame13_Pro00009061.All":[430],"participants":[431],"gave":[432],"informed":[433],"consent":[434],"before":[435],"taking":[436],"part.":[437]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-11-22T00:00:00"}